JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$147.91

Market cap

$356.28B

P/E Ratio

10.66

Dividend/share

$4.76

EPS

$13.88

Enterprise value

$363.75B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
The EPS has soared by 103% YoY
Johnson & Johnson's net income has surged by 96% YoY
The quick ratio has increased by 26% YoY but it has decreased by 4.7% QoQ
JNJ's equity is down by 10% year-on-year and by 3.4% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.jnj.com/
Peers: PFE MRK NVS SYK

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.41B
Market cap
$356.28B
Enterprise value
$363.75B
Valuations
Price to earnings (P/E)
10.66
Price to book (P/B)
5.18
Price to sales (P/S)
4.4
EV/EBIT
9.66
EV/EBITDA
8.06
EV/Sales
4.27
Earnings
Revenue
$85.16B
EBIT
$37.66B
EBITDA
$45.15B
Free cash flow
$18.25B
Per share
EPS
$13.88
Free cash flow per share
$7.2
Book value per share
$28.57
Revenue per share
$33.61
TBVPS
$38.22
Balance sheet
Total assets
$167.56B
Total liabilities
$98.78B
Debt
$29.33B
Equity
$68.77B
Working capital
$7.21B
Liquidity
Debt to equity
0.43
Current ratio
1.16
Quick ratio
0.82
Net debt/EBITDA
0.17
Margins
EBITDA margin
53%
Gross margin
68.8%
Net margin
41.3%
Operating margin
24.9%
Efficiency
Return on assets
19.5%
Return on equity
49.2%
Return on invested capital
58.5%
Return on capital employed
31.1%
Return on sales
44.2%
Dividend
Dividend yield
3.22%
DPS
$4.76
Payout ratio
34.3%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
1.49%
1 week
0.26%
1 month
-5.31%
1 year
-9%
YTD
-5.63%
QTD
-6.5%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$85.16B
Gross profit
$58.61B
Operating income
$21.21B
Net income
$35.15B
Gross margin
68.8%
Net margin
41.3%
Johnson & Johnson's net income has surged by 96% YoY
Johnson & Johnson's net margin has soared by 84% YoY
The operating income rose by 6% year-on-year
The gross profit is up by 6% YoY

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
10.66
P/B
5.18
P/S
4.4
EV/EBIT
9.66
EV/EBITDA
8.06
EV/Sales
4.27
The EPS has soared by 103% YoY
JNJ's price to earnings (P/E) is 55% lower than its 5-year quarterly average of 23.7 and 52% lower than its last 4 quarters average of 22.0
JNJ's price to book (P/B) is 14% less than its 5-year quarterly average of 6.0 and 8% less than its last 4 quarters average of 5.6
JNJ's equity is down by 10% year-on-year and by 3.4% since the previous quarter
The price to sales (P/S) is 12% less than the 5-year quarterly average of 5.0 and 10% less than the last 4 quarters average of 4.9
JNJ's revenue is up by 6% year-on-year

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has surged by 118% YoY and by 10% QoQ
The company's return on equity has surged by 108% YoY and by 4.5% QoQ
The return on assets has surged by 95% year-on-year and by 4.3% since the previous quarter
The ROS has soared by 67% YoY

Dividends

What is JNJ's dividend history
Dividend details
DPS
$4.76
Dividend yield
3.22%
Payout ratio
34.3%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 70% greater than its total liabilities
The quick ratio has increased by 26% YoY but it has decreased by 4.7% QoQ
JNJ's current ratio is up by 17% year-on-year but it is down by 4.1% since the previous quarter
Johnson & Johnson's debt is 57% less than its equity
Johnson & Johnson's debt has decreased by 26% YoY
The company's debt to equity fell by 17% YoY but it rose by 2.4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.